Contrasting Advanced Medical Isotope (OTCMKTS:RDGL) and Carlyle Secured Lending (NASDAQ:CGBD)

Carlyle Secured Lending (NASDAQ:CGBD) and Advanced Medical Isotope (OTCMKTS:RDGL) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Profitability

This table compares Carlyle Secured Lending and Advanced Medical Isotope’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Carlyle Secured Lending	27.38%	8.56%	3.90%
Advanced Medical Isotope	-6,144.90%	N/A	-113.56%

Risk and Volatility

Carlyle Secured Lending has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Comparatively, Advanced Medical Isotope has a beta of -0.64, meaning that its stock price is 164% less volatile than the S&P 500.

Institutional & Insider Ownership

24.5% of Carlyle Secured Lending shares are held by institutional investors. 0.6% of Carlyle Secured Lending shares are held by insiders. Comparatively, 18.5% of Advanced Medical Isotope shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Carlyle Secured Lending and Advanced Medical Isotope”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlyle Secured Lending	$255.57 million	2.25	$69.97 million	$1.02	11.08
Advanced Medical Isotope	$30,000.00	1,182.88	-$2.91 million	N/A	N/A

Carlyle Secured Lending has higher revenue and earnings than Advanced Medical Isotope.

Analyst Recommendations

This is a summary of current ratings for Carlyle Secured Lending and Advanced Medical Isotope, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlyle Secured Lending	0	5	3	0	2.38
Advanced Medical Isotope	0	0	0	0	0.00

Carlyle Secured Lending presently has a consensus target price of $13.60, suggesting a potential upside of 20.35%. Given Carlyle Secured Lending’s stronger consensus rating and higher possible upside, research analysts plainly believe Carlyle Secured Lending is more favorable than Advanced Medical Isotope.

Summary

Carlyle Secured Lending beats Advanced Medical Isotope on 10 of the 12 factors compared between the two stocks.

About Carlyle Secured Lending

Carlyle Secured Lending, Inc. is business development company specializing in first lien debt, senior secured loans, second lien senior secured loan unsecured debt, mezzanine debt and investments in equities. It specializes in directly investing. It specializes in middle market. It targets healthcare and pharmaceutical, aerospace and defense, high tech industries, business services, software, beverage food and tobacco, hotel gamming and leisure, banking finance insurance and in real estate sector. The fund seeks to invest across United States of America, Luxembourg, Cayman Islands, Cyprus, and United Kingdom. It invests in companies with EBITDA between $25 million and $100 million.

About Advanced Medical Isotope

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.